Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Researchers produce erythrocyte progenitor cells by transducing two genes into iPS and ES cells

Researchers produce erythrocyte progenitor cells by transducing two genes into iPS and ES cells

Older HIV-positive men at higher risk of HPV that causes anal cancer

Older HIV-positive men at higher risk of HPV that causes anal cancer

New NIH guidelines for managing opportunistic infections in children with HIV

New NIH guidelines for managing opportunistic infections in children with HIV

HPV vaccine coverage among teens still remains low than other recommended vaccinations

HPV vaccine coverage among teens still remains low than other recommended vaccinations

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

UCSF investigator receives $89 M grant to research on anal cancer in people with HIV

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

Research reveals that HPV infection is associated with higher subsequent risk of HIV infection

Adverse events linked with HPV vaccine appear to be related with media coverage

Adverse events linked with HPV vaccine appear to be related with media coverage

Hologic's Aptima HPV 16 18/45 genotype assay gets FDA approval for use on Panther system

Hologic's Aptima HPV 16 18/45 genotype assay gets FDA approval for use on Panther system

Diagnostic technology advancing but barriers prevent integration into care, IDSA report warns

Diagnostic technology advancing but barriers prevent integration into care, IDSA report warns

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Fewer doses of HPV vaccine may confer necessary long-term protection against new infection

Fewer doses of HPV vaccine may confer necessary long-term protection against new infection

Study: Single dose of HPV vaccine may be sufficient to protect cervical cancer

Study: Single dose of HPV vaccine may be sufficient to protect cervical cancer

Study examines link between geographic region and HPV vaccine uptake among young women

Study examines link between geographic region and HPV vaccine uptake among young women

African-American women less likely to benefit from HPV vaccines to prevent cervical cancer

African-American women less likely to benefit from HPV vaccines to prevent cervical cancer

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

Study shows low uptake of HPV vaccination among patients with autoimmune diseases

Merck provides overview of clinical trial program for HPV vaccine V503

Merck provides overview of clinical trial program for HPV vaccine V503

Parental perceptions pose major barrier to acceptance of HPV vaccination

Parental perceptions pose major barrier to acceptance of HPV vaccination

New article in Preventive Medicine journal explores suspicions about sexual promiscuity, vaccine safety

New article in Preventive Medicine journal explores suspicions about sexual promiscuity, vaccine safety

Study explores why girls in minority groups, low-income families don't get HPV vaccine

Study explores why girls in minority groups, low-income families don't get HPV vaccine

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.